Antibacterial 3,6-Disubstituted 4-Hydroxy-5,6-dihydro-2H-pyran-2-ones from Serratia plymuthica MF371-2

Journal of Natural Products
Joakim BjerketorpAnders Broberg

Abstract

Bioassay-guided fractionation of culture extracts of Serratia plymuthica strain MF371-2 resulted in the isolation of two new antibacterial compounds with potent activity against Gram-positive bacteria, including Staphylococcus aureus LMG 15975 (MRSA). A spectroscopic investigation, in combination with synthesis, enabled the characterization of the compounds as 3-butyryl-4-hydroxy-6-heptyl-5,6-dihydro-2H-pyran-2-one (plymuthipyranone A, 1) and 3-butyryl-4-hydroxy-6-nonyl-5,6-dihydro-2H-pyran-2-one (plymuthipyranone B, 2). The MIC values for 1 and 2 against S. aureus LMG 15975 were determined to be 1-2 μg mL-1 and 0.8 μg mL-1, respectively. Compound 2 was found to have potent activity against many strains of S. aureus, including several mupirocin-resistant strains, other species of Staphylococcus, and vancomycin-resistant enterococci. Compound 2 was slightly cytotoxic for human cells, with CC50 values between 4.7 and 40 μg mL-1, but the CC50/MIC ratio was ≥10 for many tested combinations of human cells and bacteria, suggesting its possible use as an antibacterial agent. Several analogues were synthesized with different alkyl groups in the 3- and 6-positions (6-13), and their biological properties were evaluated. It was concluded ...Continue Reading

References

May 1, 1966·Journal of General Microbiology·R Y StanierM Doudoroff
Oct 12, 2001·International Journal of Systematic and Evolutionary Microbiology·P WillumsenR M Kroppenstedt
Nov 7, 2003·Applied and Environmental Microbiology·P Maria Johansson, Sandra A I Wright
Mar 16, 2004·The Journal of Antibiotics·Maya P SinghMichael Greenstein
Mar 27, 2004·Journal of Natural Products·Martin SjögrenLars Bohlin
Sep 27, 2005·Journal of Natural Products·Anton PohankaJolanta Levenfors
Dec 13, 2006·Nature Reviews. Drug Discovery·David J PayneDavid L Pompliano
Dec 13, 2006·Nature Biotechnology·Jon ClardyChristopher T Walsh
Jul 20, 2010·Bioorganic & Medicinal Chemistry Letters·Christopher McGuiganGeoffrey Henson
Feb 18, 2011·British Journal of Pharmacology·Anthony R M CoatesYanmin Hu
Apr 20, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen W BoucherUNKNOWN Infectious Diseases Society of America
May 1, 2013·Nature Reviews. Drug Discovery·Kim Lewis
Jan 24, 2015·Nature Reviews. Drug Discovery·Alan L HarveyRonald J Quinn
Oct 29, 2015·Chembiochem : a European Journal of Chemical Biology·Judith S BauerHarald Gross
Mar 2, 2017·The Journal of Antibiotics·Evan Martens, Arnold L Demain
Mar 5, 2017·Essays in Biochemistry·Mark A T BlaskovichMatthew A Cooper

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.